Skip NavigationSkip to Content

Structural analyses of the PKA RII beta holoenzyme containing the oncogenic DnaJB1-PKAc fusion protein reveal protomer asymmetry and fusion-induced allosteric perturbations in fibrolamellar hepatocellular carcinoma

  1. Author:
    Lu, Tsan-Wen
    Aoto, Phillip C.
    Weng, Jui-Hung
    Nielsen, Cole
    Cash, Jennifer N.
    Hall, James
    Zhang,Ping
    Simon, Sanford M.
    Cianfrocco, Michael A.
    Taylor, Susan S.
  2. Author Address

    Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.Univ Michigan, Dept Biol Chem, Life Sci Inst, Ann Arbor, MI 48109 USA.Rockefeller Univ, Lab Cellular Biophys, 1230 York Ave, New York, NY 10021 USA.NCI, NIH, Frederick, MD 21701 USA.
    1. Year: 2020
    2. Date: Dec
  1. Journal: PLOS BIOLOGY
  2. PUBLIC LIBRARY SCIENCE,
    1. 18
    2. 12
  3. Type of Article: Article
  4. Article Number: e3001018
  5. ISSN: 1544-9173
  1. Abstract:

    When the J-domain of the heat shock protein DnaJB1 is fused to the catalytic (C) subunit of cAMP-dependent protein kinase (PKA), replacing exon 1, this fusion protein, J-C subunit (J-C), becomes the driver of fibrolamellar hepatocellular carcinoma (FL-HCC). Here, we use cryo-electron microscopy (cryo-EM) to characterize J-C bound to RII beta, the major PKA regulatory (R) subunit in liver, thus reporting the first cryo-EM structure of any PKA holoenzyme. We report several differences in both structure and dynamics that could not be captured by the conventional crystallography approaches used to obtain prior structures. Most striking is the asymmetry caused by the absence of the second cyclic nucleotide binding (CNB) domain and the J-domain in one of the RII beta:J-C protomers. Using molecular dynamics (MD) simulations, we discovered that this asymmetry is already present in the wild-type (WT) RII beta C-2(2) but had been masked in the previous crystal structure. This asymmetry may link to the intrinsic allosteric regulation of all PKA holoenzymes and could also explain why most disease mutations in PKA regulatory subunits are dominant negative. The cryo-EM structure, combined with small-angle X-ray scattering (SAXS), also allowed us to predict the general position of the Dimerization/Docking (D/D) domain, which is essential for localization and interacting with membrane-anchored A-Kinase-Anchoring Proteins (AKAPs). This position provides a multivalent mechanism for interaction of the RII beta holoenzyme with membranes and would be perturbed in the oncogenic fusion protein. The J-domain also alters several biochemical properties of the RII beta holoenzyme: It is easier to activate with cAMP, and the cooperativity is reduced. These results provide new insights into how the finely tuned allosteric PKA signaling network is disrupted by the oncogenic J-C subunit, ultimately leading to the development of FL-HCC.

    See More

External Sources

  1. DOI: 10.1371/journal.pbio.3001018
  2. PMID: 33370777
  3. PMCID: PMC7793292
  4. WOS: 000603611300004

Library Notes

  1. Fiscal Year: FY2020-2021
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel